Bioimpacts. 2020;10(3): 187-193.
doi: 10.34172/bi.2020.23
PMID: 32793441
PMCID: PMC7416006
Scopus ID: 85089711371
  Abstract View: 255
  PDF Download: 126
  Full Text View: 38

Original Research

Designing a light-activated recombinant alpha hemolysin for colorectal cancer targeting

Siamak Alizadeh 1,2, Abolfazl Barzegari 2, Abolghasem Esmaeili 1*, Yadollah Omidi 2,3* ORCID logo

1 Department of Cell and Molecular Biology & Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran
2 Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran
3 Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
*Corresponding authors: Yadollah Omidi, Email: ; Abolghasem Esmaeili, Email: aesmaeili@sci.ui.ac.ir yomidi@yahoo.com


Introduction: Colorectal cancer (CRC) is one of the main health burden worldwide, which can cause major economic and physiological problems along with relatively high rate of mortality. It is important to develop new methods for the localized delivery of recombinant protein therapeutics, in large part due to the failure of conventional therapies in most cases. Since E. coli Nissle 1917 (EcN) does not produce any virulence factors, here we used these bacteria with the light-activated promoter system to deliver therapeutic agents in the desired location and time.
Methods: In this study, Staphylococcus aureus alpha hemolysin (SAH), after codon usage optimization, was cloned into blue light activating vector (pDawn) and transferred to EcN strain. Then, the functionality and cytotoxicity of secreted alpha hemolysin was evaluated in the SW480 colon cancer cell line by using different experiments, including blood agar test, flow cytometry analysis, and DAPI staining.
Results: Our findings revealed that EcN can produce functional SAH under the blue light irradiation against SW480 cancer cells. Moreover, cytotoxicity assays confirmed the dose- and time-dependent toxicity of this payload (SAH) against SW480 cancer cells.
Conclusion: Based on our results, EcN is proposed as an appropriate light-activated vehicle for delivery of anticancer agents to the target cancer cells/tissues.
Keywords: Alpha hemolysin, Colon cancer, E. coli Nissle 1917, Light-activated vector, Staphylococcus aureus

First Name
Last Name
Email Address
Security code

Abstract View: 255

Your browser does not support the canvas element.

PDF Download: 126

Your browser does not support the canvas element.

Full Text View: 38

Your browser does not support the canvas element.

Submitted: 11 Jul 2019
Revision: 25 Aug 2019
Accepted: 31 Aug 2019
ePublished: 02 Nov 2019
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)